A biotechnology company focused on developing precision therapies for cancer and autoimmune diseases using proprietary technology platforms.

Hummingbird Bioscience

Hummingbird Bioscience is a data-driven precision biotherapeutics team discovering and developing transformative biologic medicines for hard-to-treat diseases. The Hummingbird Bioscience model combines computational and systems biology, and wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development. We harness this integrated approach across target identification and patient selection, enabling our team to increase the efficiency of translating novel scientific insights while reducing the inherent risk in drug discovery and development. At Hummingbird Bioscience, our commitment to rigorous science, teamwork, and intellectual integrity underpins our passion to accelerate the journey of new drugs from concept to clinic. 

Sign up for our updates here: https://bit.ly/HMBDNews

Heritas Capital

Amgen Ventures

Mirae Asset Venture Investment

Pureos Bioventures

Seeds Capital

Novo Holdings

Octagon Capital Advisors

Polaris Partners

Droia Ventures

EDBI

Frazier Healthcare Partners

Kon Yew Kwek, BMBCh, DPhil, Senior Vice President of Clinical Development at Hummingbird Bioscience will share our clinical development strategy and progress at the SCRI Clinical Trials Symposium 2024 (30-31 July): https://bit.ly/3xIprzF 

Kon Yew will also participate in a panel discussing the possibilities for biotechs conducting clinical trials in Singapore. 

 31 July 2024 (Day 2)
 Time: 11 am – 12.30 pm 
 
 Organized by the Singapore Clinical Research Institute (SCRI), the two-day event aims to showcase the impact of and opportunities for clinical trials in Singapore. 
 
 #clinicaldevelopment #clinicaltrials #singapore

Hummingbird Bioscience partnered with the Children's Wishing Well to spark children’s interest in biology and conservation. In a visit to Science Centre Singapore last month, volunteers from our team accompanied ~40 children on the “Young Geneticist Trail”, for the children to learn about DNA and genetic inheritance. The children also viewed a screening of the “Jane Goodall – Reasons for Hope” documentary at the Omni-theatre. We hope the children enjoyed their day! 

#csr #scienceeducation #biology

Gary Khoo 邱思贤, VP of CMC at Hummingbird Bioscience will speak at a panel at World ADC Asia (25-27 June, Incheon, South Korea). Gary will share about how we manage our ADC production processes. The panel will discuss supply chain management of ADC components in Asia Pacific, and navigation of European and American markets. If you will be at World ADC Asia, connect with Gary at the panel discussion. 

#worldADC #ADC World ADC Event Series

Hummingbird Bioscience will present its next-generation antibody-drug conjugate capabilities (ADC) at PEGS Boston 2024 (13-17 May). 
 
For the first time, the company will present how its proprietary 4th generation ADC platform overcomes the resistance observed with earlier generation single payload ADCs. The company will also present how its proprietary Rational Antibody Discovery (RAD) platform enables epitope-directed discovery against challenging targets for optimal drug properties. 
 
Read more on the press release: https://bit.ly/3UGUYd0

This is the third year that Hummingbird Bioscience has collaborated with South West Community Development Council and People's Association to give back to the community. On 23rd and 24th February 2024, our CSR committee and volunteers packed and distributed bags of food and necessities to households in Telok Blangah. We hope that our contributions have made a positive impact on the community. 
 
The initiative is part of a larger program (Adopt @ South West) by the South West CDC, to provide well-rounded assistance in the areas of social support & wellness, education & enrichment, and home maintenance & improvement.

The Hummingbird Bioscience team will present our clinical development, CMC, and regulatory capabilities at Clinical Trials Festival Asia and Biologics Manufacturing Asia, at Marina Bay Sands Expo & Convention Centre in Singapore on 20-21 March. 
 
Carlo Polo, Senior Director of Regulatory Science, and Kon Yew Kwek, Senior Vice President of Clinical Development will present regulatory insights on Asia’s clinical trials and our approach to precision oncology. 
 
Gary Khoo, Vice President of CMC, will present the key considerations in developing and manufacturing next generation ADCs. Gary will also be on a panel discussing the Asia biomanufacturing market. 
 
IMAPAC #clinicaldevelopment #regulatoryscience #ADC

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Jul 11, 2024 2:23 PM	2daed3e1
public peers	general	Jul 11, 2024 2:23 PM	8e684728
news daily refresh	general	Jul 11, 2024 2:23 PM	ceb31e3f
news processing daily refresh	general	Jul 11, 2024 2:23 PM	8ed07552
news impact assignment daily	general	Jul 11, 2024 2:23 PM	75b22854
news processing basic	general	Jul 11, 2024 2:23 PM	d7d93d52
company summary	general	Jul 11, 2024 11:04 PM	6cf44727
signals	general	Jul 11, 2024 2:23 PM	fcaebaf7
crunchbase trigger	general	Nov 18, 2024 2:12 PM	e428366d
crunchbase profile	general
li profile	general	Jul 11, 2024 2:23 PM	c655bd60
translate crunchbase fundingrounds	general
peers	general	Jul 11, 2024 2:23 PM	6557b40e
news basic	general	Jul 11, 2024 2:23 PM	6db4a45f
bundesanzeiger	filings	Jul 11, 2024 2:23 PM	ab130d47
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

HUMM

COM:HUMMINGBIRDBIOSCIENCE

Hummingbird Bioscience